Table 1 Clinicopathologic characteristics of patients and univariate logistic analysis in patients.
Clinicopathological parameters | Development set (n = 1728) | Validation set (n = 741) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
N | Pulmonary infection | OR (95% CI)d | P | N | Pulmonary infection | OR (95% CI)d | P | ||||
Negative | Positive | Negative | Positive | ||||||||
ALL | 1728 | 1688 | 40 | 741 | 716 | 25 | |||||
Gender | Male | 1154 | 1124 | 30 | 1.51 (0.78–2.23) | 0.267 | 470 | 455 | 15 | 0.86 (0.05–1.68) | 0.718 |
Female | 574 | 564 | 10 | Ref | 271 | 261 | 10 | Ref | |||
Age (\(\bar{{\rm{\chi }}}\) ± S) | 55.18 ± 10.62 | 57.45 ± 11.26 | 1.02 (0.99–1.05) | 0.183 | — | 55.90 ± 10.56 | 56.72 ± 7.19 | 1.01 (0.97–1.05) | 0.701 | ||
Body mass index (kg/m2)e | <18.5 | 205 | 197 | 8 | 0.80 (0.25–1.35) | 0.435 | 93 | 92 | 1 | 2.28 (1.57–2.98) | 0.022 |
18.5–25.0 | 1281 | 1255 | 26 | 539 | 523 | 16 | |||||
>25.0 | 242 | 236 | 6 | 109 | 101 | 8 | |||||
Smoking (pack-y) | 13.99 ± 20.81 | 22.25 ± 24.04 | 1.01 (1.00–1.03) | 0.015 | — | 14.23 ± 20.53 | 13.64 ± 25.80 | 1.00 (0.98–1.02) | 0.889 | ||
ASA score | 1 + 2 | 1539 | 1508 | 31 | Ref | 0.022 | 664 | 643 | 21 | Ref | 0.355 |
3 + 4 | 189 | 180 | 9 | 2.43 (1.67–3.19) | 77 | 73 | 4 | 1.68 (0.58–2.77) | |||
COPD | Yes | 61 | 56 | 5 | 4.16 (3.19–5.14) | 0.004 | 20 | 16 | 4 | 8.33 (7.16–9.51) | 0.000 |
No | 1667 | 1632 | 35 | Ref | 721 | 700 | 21 | Ref | |||
Comorbidities excepting COPD | Yes | 480 | 467 | 13 | 1.26 (0.59–1.93) | 0.501 | 203 | 192 | 11 | 2.14 (1.34–2.95) | 0.064 |
No | 1248 | 1221 | 27 | Ref | 538 | 524 | 14 | Ref | |||
Anemiaa | No | 1086 | 1065 | 21 | Ref | 0.174 | 473 | 461 | 12 | Ref | 0.134 |
Yes | 642 | 623 | 19 | 1.55 (0.92–2.18) | 278 | 265 | 13 | 1.84 (1.04–2.64) | |||
Albumin (g/L) | ≥35 | 1361 | 1336 | 25 | Ref | 0.013 | 573 | 554 | 19 | Ref | 0.872 |
<35 | 367 | 352 | 15 | 2.28 (1.63–2.93) | 168 | 162 | 6 | 1.08 (0.15–2.01) | |||
Pre-operative blood transfusion | Yes | 161 | 151 | 10 | 3.39 (2.66–4.13) | 0.001 | 62 | 60 | 2 | 0.95 (−0.52–2.42) | 0.946 |
No | 1567 | 1537 | 30 | Ref | 679 | 656 | 23 | Ref | |||
Operation procedure | Open | 1339 | 1301 | 38 | 5.65 (4.23–7.08) | 0.017 | 565 | 544 | 21 | 1.66 (0.58–2.74) | 0.359 |
Laparoscopy | 389 | 387 | 2 | Ref | 176 | 172 | 4 | Ref | |||
Extent of gastrectomy | Total | 415 | 400 | 15 | 1.93 (1.28–2.58) | 0.047 | 166 | 158 | 8 | 1.66 (0.80–2.52) | 1.359 |
Subtotalb | 1313 | 1288 | 25 | Ref | 575 | 558 | 17 | Ref | |||
Combined multi-organ resection | Yes | 162 | 151 | 11 | 3.86 (3.15–4.57) | 0.000 | 58 | 54 | 4 | 2.34 (1.23–3.44) | 0.132 |
No | 1566 | 1537 | 29 | Ref | 683 | 662 | 21 | Ref | |||
Operation time (hour) | >4 | 369 | 352 | 17 | 2.81 (2.17–3.44) | 0.002 | 165 | 153 | 12 | 3.40 (2.59–4.20) | 0.003 |
≤4 | 1359 | 1336 | 23 | Ref | 576 | 563 | 13 | Ref | |||
Amount of bleeding (ml) | >300 | 341 | 328 | 13 | 2.00 (1.32–2.67) | 0.044 | 153 | 146 | 7 | 1.52 (0.63–2.41) | 0.359 |
≤300 | 1387 | 1360 | 27 | Ref | 588 | 570 | 18 | Ref | |||
Intra-operative blood transfusion | Yes | 141 | 130 | 11 | 4.55 (3.83–5.26) | 0.000 | 56 | 54 | 2 | 1.07 (−0.41–2.54) | 0.932 |
No | 1587 | 1558 | 29 | Ref | 685 | 662 | 23 | Ref | |||
Tumor location | Upper third | 145 | 137 | 8 | 3.90 (3.04–4.76) | 0.002 | 71 | 67 | 4 | 1.83 (0.70–2.95) | 0.293 |
Middle third | 431 | 416 | 15 | 2.41 (1.70–3.11) | 0.014 | 164 | 159 | 5 | 0.96 (−0.06–1.98) | 0.942 | |
Lower third | 1152 | 1135 | 17 | Ref | 506 | 490 | 16 | Ref | |||
Tumor size (cm)e | <2.5 | 373 | 370 | 3 | 2.06 (1.56–2.55) | 0.004 | 144 | 139 | 5 | 1.13 (0.51–1.75) | 0.692 |
2.5–5.0 | 949 | 928 | 21 | 431 | 418 | 13 | |||||
>5.0 | 406 | 390 | 16 | 166 | 159 | 7 | |||||
TNM stagec,e | I | 449 | 444 | 5 | 1.38 (0.97–1.79) | 0.124 | 200 | 195 | 5 | 1.41 (0.89–1.92) | 0.194 |
II | 365 | 354 | 11 | 149 | 146 | 3 | |||||
III | 914 | 890 | 24 | 392 | 375 | 17 | |||||